Voices
Giuseppe Curigliano
Giuseppe Curigliano/bigagainstbreastcancer.org

Giuseppe Curigliano: The ROME Trial Marks a Milestone for Italy’s Precision Oncology Platform

Giuseppe Curigliano, President Elect of ESMO and Member of the Editorial Board at OncoDaily, shared a post on LinkedIn:

“The ROME trial marks a milestone for Italy’s precision oncology platform: 6 years of dedication, 40 centers, 1,794 patients sequenced. A national effort to bring genomics to the heart of cancer care.”

Title: Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial

Authors: Paolo Marchetti, Giuseppe Curigliano, Mauro Biffoni, Sara Lonardi, Simone Scagnoli, Lorenzo Fornaro, Valentina Guarneri, Ugo De Giorgi, Paolo Antonio Ascierto, Giovanni Blandino, Giulia D’Amati, Massimo Aglietta, Chiara Cremolini, Pierfranco Conte, Edoardo Crimini, Maurizio Ceracchi, Simona Pisegna, Sofia Verkhovskaia, Roberto Bordonaro, Sergio Bracarda, Giovanni Butturini, Lucia Del Mastro, Andrea DeCensi, Agnese Fabbri

Read the Full Article.

Giuseppe Curigliano: The ROME Trial Marks a Milestone for Italy’s Precision Oncology Platform

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research

Oncologist-Near-Me-OncoDaily

Agnese Fabbri Andrea DeCensi cancer Chiara Cremolini Edoardo Crimini Giovanni Blandino Giovanni Butturini Giulia d'Amati Giuseppe Curigliano Lorenzo Fornaro Lucia Del Mastro Massimo Aglietta Maurizio Ceracchi Mauro Biffoni OncoDaily Oncology Paolo Antonio Ascierto Paolo Marchetti Pierfranco Conte Roberto Bordonaro Sara Lonardi Sergio Bracarda Simona Pisegna Simone Scagnoli Sofia Verkhovskaia Ugo de Giorgi Valentina Guarneri